Ternant, D.; Le Tilly, O.; Picon, L.; Moussata, D.; Passot, C.; Bejan-Angoulvant, T.; Desvignes, C.; Mulleman, D.; Goupille, P.; Paintaud, G.
Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model. Pharmaceutics 2021, 13, 1821.
https://doi.org/10.3390/pharmaceutics13111821
AMA Style
Ternant D, Le Tilly O, Picon L, Moussata D, Passot C, Bejan-Angoulvant T, Desvignes C, Mulleman D, Goupille P, Paintaud G.
Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model. Pharmaceutics. 2021; 13(11):1821.
https://doi.org/10.3390/pharmaceutics13111821
Chicago/Turabian Style
Ternant, David, Olivier Le Tilly, Laurence Picon, Driffa Moussata, Christophe Passot, Theodora Bejan-Angoulvant, Céline Desvignes, Denis Mulleman, Philippe Goupille, and Gilles Paintaud.
2021. "Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model" Pharmaceutics 13, no. 11: 1821.
https://doi.org/10.3390/pharmaceutics13111821
APA Style
Ternant, D., Le Tilly, O., Picon, L., Moussata, D., Passot, C., Bejan-Angoulvant, T., Desvignes, C., Mulleman, D., Goupille, P., & Paintaud, G.
(2021). Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model. Pharmaceutics, 13(11), 1821.
https://doi.org/10.3390/pharmaceutics13111821
